SCHEMBL2717150

SCHEMBL2717150

CCN(Cc1cccs1)C(=O)C=Cc1ccc(F)cc1

nearest known ligand 0.80

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ TRPM8 Q7Z2W7 10/20 0.80
▸ RECQL P46063 1/20 0.56
▸ NPC1 O15118 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ MAOA P21397 1/20 0.46
▸ MAOB P27338 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2717146 1.00 TRPM8 (0.80) TRPM8RECQLNPC1L3MBTL1MAPK1
SCHEMBL2718605 0.89 TRPM8 (1.00) TRPM8NPC1L3MBTL1ALDH1A1HPGD
SCHEMBL2718603 0.89 TRPM8 (1.00) TRPM8NPC1L3MBTL1ALDH1A1HPGD
SCHEMBL2717965 0.89 TRPM8 (0.82) TRPM8NPC1L3MBTL1MAPK1ALDH1A1
SCHEMBL2717967 0.89 TRPM8 (0.82) TRPM8NPC1L3MBTL1MAPK1ALDH1A1
SCHEMBL2720521 0.89 TRPM8 (0.81) TRPM8NPC1L3MBTL1MAPK1ALDH1A1
SCHEMBL2720524 0.89 TRPM8 (0.81) TRPM8NPC1L3MBTL1MAPK1ALDH1A1
SCHEMBL10168528 0.88 TRPM8 (0.80) TRPM8NPC1L3MBTL1ALDH1A1HPGD
SCHEMBL2721442 0.87 TRPM8 (0.68) TRPM8NPC1L3MBTL1MAPK1MAOA
SCHEMBL30582839 0.87 TRPM8 (0.68) TRPM8NPC1L3MBTL1MAPK1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025132323-A1 COMPOSITIONS COMPRISING A SUNSCREEN ACTIVE AGENT DSM-FIRMENICH AG (CH) 2025-06-26 — — WO disclosed
EP-3470407-B1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED (US) 2024-01-24 — — EP disclosed
EP-3478089-B1 PLATED YEAST FORMULATIONS FIRMENICH & CIE (CH) 2021-11-03 — — EP disclosed
US-11160894-B2 Perfume emanating device FIRMENICH SA (CH) 2021-11-02 — — US disclosed
US-11091734-B2 Plated yeast formulations FIRMENICH SA (CH) 2021-08-17 — — US disclosed
US-10953007-B2 Compounds useful as modulators of TRPM8 FIRMENICH INCORPORATED (US) 2021-03-23 — — US disclosed
EP-3478089-A1 PLATED YEAST FORMULATIONS Firmenich SA (CH) 2019-05-08 — — EP disclosed
EP-3470407-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2019-04-17 — — EP disclosed
EP-2635572-B1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX INC (US) 2018-10-17 — — EP disclosed
US-20180289704-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED 2018-10-11 — — US disclosed
US-20180264156-A1 PERFUME EMANATING DEVICE FIRMENICH SA (CH) 2018-09-20 — — US disclosed
EP-3355944-A1 PERFUME EMANATING DEVICE Firmenich SA (CH) 2018-08-08 — — EP disclosed
US-10016418-B2 Compounds useful as modulators of TRPM8 Seaomyx, Inc. (US) 2018-07-10 — — US disclosed
WO-2018002331-A1 PLATED YEAST FORMULATIONS FIRMENICH SA (CH) 2018-01-04 — — WO disclosed
US-20160317532-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED 2016-11-03 — — US disclosed
US-9394287-B2 Compounds useful as modulators of TRPM8 SENOMYX, INC. (US) 2016-07-19 — — US disclosed
US-20130324557-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2013-12-05 — — US disclosed
EP-2635572-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2013-09-11 — — EP disclosed
WO-2012061698-A9 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2012-09-13 — — WO disclosed
WO-2012061698-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2012-05-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11160894-B2 Perfume emanating device DPM1, SURF4, FAAH2 TRPM8 151/4885RECQL 1864/4885NPC1 1230/4885
US-10953007-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM7, TRPM6 TRPM8 1/4885RECQL 2918/4885NPC1 1050/4885
US-10016418-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM7, TRPM6 TRPM8 1/4885RECQL 2918/4885NPC1 1050/4885
US-20180264156-A1 PERFUME EMANATING DEVICE DPM1, SURF4, FAAH2 TRPM8 151/4885RECQL 1864/4885NPC1 1230/4885
US-20160317532-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM7, TRPM6 TRPM8 1/4885RECQL 2918/4885NPC1 1050/4885
US-20130324557-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM7, TRPM6 TRPM8 1/4885RECQL 2918/4885NPC1 1050/4885
US-20180289704-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM7, TRPM6 TRPM8 1/4885RECQL 2918/4885NPC1 1050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback